No profile data available.
Picard Medical, Inc. (PMI) is a healthcare company in the heart treatment equipment industry, based in Tucson, United States, with about 75 full-time employees.
It reported revenue of $4.94 million for fiscal year 2025, up 12.5% from fiscal year 2024, and net income of -$27.00 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $2.95 million, up 38.6% from a year before. Its largest business segment, Product, brought in 73% of segment revenue in fiscal year 2025. Its market capitalization was $271.96 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.
Picard Medical reported $4.94 million in revenue for fiscal year 2025, up 12.5% from $4.39 million in fiscal year 2024. In Q2 2026 revenue was $2.95 million.
Product, with $4.75 million or 73% of segment revenue in fiscal year 2025. Next: Rentals (27%).
$271.96 million as of December 4, 2025.
Listed companies of a similar size in the same industry (heart treatment equipment) include Kestra Medical Technologies, Ltd. (KMTS), Anteris Technologies Global Corp. (AVR), Orchestra BioMed Holdings, Inc. (OBIO), Stereotaxis, Inc. (STXS).